Medicare Enrolled
Dr. Kin Lam, MD
Hematology & Oncology · New York, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lam?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lam
Dr. Kin Lam is a hematology & oncology specialist in New York, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lam performed 3,995 Medicare services across 1,749 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lam received a total of $103,723 from 130 pharmaceutical and/or device companies across 2600 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lam is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 25% volume in NY
$103,723 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,995
Medicare services
Top 25% in NY for hematology & oncology
1,749
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~200 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
829 | $106 | $207 |
| COVID-19 test, self-administered An FDA-approved, authorized, or cleared test kit for nonprescription self-administered and self-collected use. This code represents the provision of one test count. |
539 | $12 | $15 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
503 | $53 | $91 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
334 | $5 | $17 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
328 | $8 | $17 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
253 | $0 | $3 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
226 | $70 | $146 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
110 | $69 | $134 |
| Annual depression screening | 105 | $21 | $30 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
94 | $41 | $69 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
75 | $25 | $58 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
73 | $13 | $35 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
61 | $76 | $100 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
60 | $47 | $90 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
58 | $13 | $41 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
57 | $35 | $50 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
54 | $148 | $210 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
48 | $66 | $147 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
34 | $34 | $90 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
31 | $0 | $1 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
28 | $136 | $273 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
27 | $8 | $102 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
26 | $61 | $130 |
| Annual intensive behavioral therapy for cardiovascular disease, 15 minutes A yearly, in-person session focused on intensive behavioral therapy to help manage cardiovascular disease. The session lasts for 15 minutes and is conducted with the patient individually. |
17 | $30 | $43 |
| Vaccine administration The process of giving a vaccine to a patient. This code covers the administration service only and does not include the cost of the vaccine itself. |
13 | $19 | $50 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
12 | $179 | $326 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.4% high complexity
7.8% medium
90.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$103,723
Total received (2018-2024)
Avg $14,818/year across 7 years
Top 8% in NY for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
130
Companies
2,600
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$54,478 (52.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$42,837 (41.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$6,110 (5.9%)
Other
Charitable contributions, space rental, and other categories
$299 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$9,240
2023
$11,749
2022
$17,137
2021
$8,728
2020
$19,513
2019
$26,434
2018
$10,923
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$653
GlaxoSmithKline, LLC.
$553
Daiichi Sankyo Inc.
$512
PFIZER INC.
$491
Merck Sharp & Dohme LLC
$446
Janssen Biotech, Inc.
$416
Novartis Pharmaceuticals Corporation
$380
Rigel Pharmaceuticals, Inc.
$364
Amgen Inc.
$360
Lilly USA, LLC
$314
Novo Nordisk Inc
$302
Celgene Corporation
$288
Takeda Pharmaceuticals U.S.A., Inc.
$280
Myriad Genetic Laboratories, Inc.
$258
E.R. Squibb & Sons, L.L.C.
$244
Gilead Sciences, Inc.
$238
Stemline Therapeutics Inc.
$220
Exact Sciences Corporation
$206
Incyte Corporation
$204
BeiGene USA, Inc.
$164
Exelixis Inc.
$161
Mirati Therapeutics, Inc.
$153
Eisai Inc.
$150
ARRAY BIOPHARMA INC
$147
Bayer Healthcare Pharmaceuticals Inc.
$145
SOBI, INC
$143
Tempus AI, Inc
$120
Boehringer Ingelheim Pharmaceuticals, Inc.
$114
ABBVIE INC.
$109
Astellas Pharma US Inc
$103
GENZYME CORPORATION
$101
Agios Pharmaceuticals, Inc.
$92
PUMA BIOTECHNOLOGY, INC.
$91
JAZZ PHARMACEUTICALS INC.
$80
EMD Serono, Inc.
$70
TAIHO ONCOLOGY, INC.
$55
Regeneron Healthcare Solutions, Inc.
$52
Verity Pharmaceuticals Inc.
$51
Karyopharm Therapeutics Inc.
$47
Deciphera Pharmaceuticals Inc.
$45
Aveo Pharmaceuticals, Inc.
$33
Chiesi USA, Inc.
$30
Genmab U.S., Inc.
$28
Kowa Pharmaceuticals America, Inc.
$27
Pharmacosmos Therapeutics Inc.
$25
RECORDATI_RARE_DISEASES_INC.
$23
Secura Bio, Inc.
$23
Ipsen Biopharmaceuticals, Inc
$23
SHIELD THERAPEUTICS INC
$23
Sumitomo Pharma America, Inc.
$23
Phathom Pharmaceuticals, Inc.
$22
SpringWorks Therapeutics, Inc.
$20
Acrotech Biopharma Inc.
$19
Top 3 companies account for 18.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$27,103
Boehringer Ingelheim Pharmaceuticals, Inc.
$12,558
Exelixis Inc.
$5,325
E.R. Squibb & Sons, L.L.C.
$3,948
Novartis Pharmaceuticals Corporation
$3,453
GlaxoSmithKline, LLC.
$2,975
PFIZER INC.
$2,837
Eisai Inc.
$2,620
Amgen Inc.
$2,403
Janssen Biotech, Inc.
$2,363
TAIHO ONCOLOGY, INC.
$2,255
Gilead Sciences, Inc.
$1,931
Kite Pharma, Inc.
$1,758
Lilly USA, LLC
$1,620
Merck Sharp & Dohme Corporation
$1,528
Novo Nordisk Inc
$1,388
Takeda Pharmaceuticals U.S.A., Inc.
$1,377
Celgene Corporation
$1,363
Merck Sharp & Dohme LLC
$1,113
Daiichi Sankyo Inc.
$1,059
GENZYME CORPORATION
$1,046
Rigel Pharmaceuticals, Inc.
$1,042
Astellas Pharma US Inc
$1,016
Bayer HealthCare Pharmaceuticals Inc.
$890
Seagen Inc.
$866
Puma Biotechnology, Inc.
$855
Amarin Pharma Inc.
$778
Incyte Corporation
$752
Genentech USA, Inc.
$690
AbbVie, Inc.
$687
EMD Serono, Inc.
$574
Mirati Therapeutics, Inc.
$531
BeiGene USA, Inc.
$495
AbbVie Inc.
$480
ABBVIE INC.
$452
ARRAY BIOPHARMA INC
$439
EISAI INC.
$426
SOBI, INC
$406
Kowa Pharmaceuticals America, Inc.
$389
PUMA BIOTECHNOLOGY, INC.
$370
TESARO, Inc.
$365
Athenex Pharmaceutical Division, LLC
$350
Dova Pharmaceuticals
$342
Myriad Genetic Laboratories, Inc.
$332
Horizon Therapeutics plc
$314
Foundation Medicine, Inc.
$309
Clovis Oncology, Inc.
$302
NOVARTIS PHARMACEUTICALS CORPORATION
$299
Stemline Therapeutics Inc.
$283
Alexion Pharmaceuticals, Inc.
$270
OPKO Pharmaceuticals, LLC
$252
COMSORT, Inc
$250
Bayer Healthcare Pharmaceuticals Inc.
$245
Deciphera Pharmaceuticals Inc.
$233
Regeneron Healthcare Solutions, Inc.
$232
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$228
Exact Sciences Corporation
$228
Kyowa Kirin, Inc.
$219
SANOFI-AVENTIS U.S. LLC
$203
Novocure GmbH
$200
INTRA-SANA LABORATORIES
$200
Myovant Sciences Inc.
$197
JAZZ PHARMACEUTICALS INC.
$193
Janssen Pharmaceuticals, Inc
$187
Allergan Inc.
$149
Sobi, Inc
$148
Teva Pharmaceuticals USA, Inc.
$145
Pharmacyclics LLC, An AbbVie Company
$143
Taiho Oncology, Inc.
$131
Tempus AI, Inc
$120
ARBOR PHARMACEUTICALS, INC.
$110
Verastem, Inc.
$105
Agios Pharmaceuticals, Inc.
$92
Seattle Genetics, Inc.
$89
Ipsen Biopharmaceuticals, Inc
$88
Verity Pharmaceuticals Inc.
$85
Arbor Pharmaceuticals, Inc.
$85
AKEBIA THERAPEUTICS INC
$84
Blueprint Medicines Corporation
$82
Acrotech Biopharma Inc.
$75
SANOFI PASTEUR INC.
$74
IBSA Pharma Inc.
$71
Jazz Pharmaceuticals Inc.
$69
Advanced Accelerator Applications
$68
RECORDATI_RARE_DISEASES_INC.
$66
West-Ward Pharmaceuticals
$57
Genmab U.S., Inc.
$56
Nestle HealthCare Nutrition Inc.
$55
Shionogi Inc
$51
Karyopharm Therapeutics Inc.
$47
Hikma Pharmaceuticals USA
$46
Sumitomo Pharma America, Inc.
$46
Pharmacyclics LLC, an AbbVie Company
$44
TerSera Therapeutics LLC
$41
EUSA Pharma (US) LLC
$40
Acceleron Pharma, Inc.
$40
Epizyme, Inc.,
$38
Secura Bio, Inc.
$38
Coherus Biosciences Inc.
$34
Aveo Pharmaceuticals, Inc.
$33
Chiesi USA, Inc.
$30
SERVIER PHARMACEUTICALS LLC
$25
Pharmacosmos Therapeutics Inc.
$25
SUN PHARMACEUTICAL INDUSTRIES INC.
$24
CTI BioPharma Corp.
$23
SHIELD THERAPEUTICS INC
$23
G1 Therapeutics, Inc.
$22
Phathom Pharmaceuticals, Inc.
$22
Vifor Pharma, Inc.
$21
Shire North American Group Inc
$21
TG Therapeutics, Inc.
$20
SpringWorks Therapeutics, Inc.
$20
Insmed, Inc.
$20
Seqirus USA Inc
$20
Otsuka America Pharmaceutical, Inc.
$20
Midatech Pharma US Inc
$19
Immunomedics, Inc.
$19
Bio Products Laboratory USA, Inc.
$19
Novocure Inc.
$18
Acrotech Biopharma LLC
$18
Relypsa, Inc.
$18
PharmaEssentia USA Corporation
$18
AMAG Pharmaceuticals, Inc.
$17
Circassia Pharmaceuticals Inc
$16
Fortovia Therapeutics, Inc.
$15
Sanofi Pasteur Inc.
$15
Horizon Pharma plc
$15
Amneal Pharmaceuticals LLC
$15
Avion Pharmaceuticals
$14
Mission Pharmacal Company
$11
Top 3 companies account for 43.4% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADCETRIS · AFINITOR · AIRSUPRA · ALIMTA · ALUNBRIG · ANORO · ANORO ELLIPTA · AREXVY · ASPARLAS · AUGTYRO · AURYXIA · Abraxane · Aimovig · Alecensa · Aliqopa · Aranesp · Arikayce · Auryxia · Avastin · BALVERSA · BAVENCIO · BELEODAQ · BELSOMRA · BENDEKA · BENLYSTA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BREO · BREZTRI · BRUKINSA · BYSTOLIC · Balversa · Bavencio · Binosto · CABLIVI · CABOMETYX · CAMZYOS · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COPIKTRA · COSELA · CREON · CYRAMZA · Cabometyx · Cologuard Collection Kit · Copiktra · Creon · DARZALEX · DAURISMO · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMGALITY · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EUCRISA · EVENITY · Edarbi · Edarbyclor · Enhertu · Epclusa · Epkinly · Erleada · FARESTON · FARXIGA · FARYDAK · FASLODEX · FERAHEME · FLUBLOK QUADRIVALENT · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUCELVAX QUADRIVALENT · FLUZONE HIGH-DOSE · FLUZONE QUADRIVALENT · FOLOTYN · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAVRETO · GILOTRIF · GRANIX · Gammaplex · Gelclair · Gloperba · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · IMJUDO · INJECTAFER · INLYTA · Idhifa · Imbruvica · Inrebic · JAKAFI · JANUMET · JANUVIA · JARDIANCE · JAYPIRCA · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · KRYSTEXXA · Kerendia · Kyprolis · LENVIMA · LIBTAYO · LINZESS · LIVALO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Licart · Livalo · Lonsurf · MEKINIST · MONJUVI · MOUNJARO · MYCAPSSA · MYLOTARG · MYRISK · Mitigare · Mulpleta · NATPARA · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · OPTUNE LUA (NOVOTTF-200T) · ORGOVYX · Onivyde · Orserdu · Otezla · Ozempic · PADCEV · PEMAZYRE · PENNSAID · PIQRAY · PLUVICTO · POTELIGEO · PRALUENT · PRECISETUMOR · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PROMACTA · PYRUKYND · Perjeta · Pomalyst · Prolia · QINLOCK · QULIPTA · RAYALDEE · RAYOS · REBLOZYL · RELTONE 200 MG · RETACRIT · RETEVMO · RUXIENCE · RYBELSUS · RYBREVANT · RYDAPT · Rayaldee · Reblozyl · Repatha · Revlimid · Rezlidhia · Rubraca · Rybelsus · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SOMATULINE DEPOT · SPIRIVA RESPIMAT · SPRYCEL · STEGLUJAN · STIOLTO RESPIMAT · SUTENT · SYLVANT · SYMBICORT · SYNTHROID · Stivarga · Sylvant · TABRECTA · TAFINLAR · TAGRISSO · TALVEY · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEPMETKO · TEVIMBRA · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tazverik · Tecentriq · Trelstar · Trodelvy · UBRELVY · UKONIQ · ULTOMIRIS · UNITHROID · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VIBERZI · VOQUEZNA · VOTRIENT · Vascepa · Veltassa · Vemlidy · Venclexta · Vitrakvi · Vonjo · Vyloy · WELIREG · XALKORI · XARELTO · XIFAXAN · XIFAXANIBSD · XOSPATA · XPOVIO · XT CDX · XTANDI · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZENPEP · ZEPZELCA · ZOLADEX · ZORYVE · ZYTIGA · Zoladex · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (52%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for hematology & oncology in NY.
Geographic Context
Hematology & oncology specialists within 10 mi
726
Per 100K population
44.6
County median income
$104,553
Nearest hospital
NY EYE AND EAR INFIRMARY OF MOUNT SINAI
1.2 mi
1.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lam is a clinical cardiology specialist, with above-average Medicare volume (top 25% in NY), with low-engagement industry engagement in the top 8% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lam experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Lam performed 829 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lam receive payments from pharmaceutical companies?
Yes. Dr. Lam received a total of $103,723 from 130 companies across 2,600 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lam's costs compare to other hematology & oncology specialists in New York?
Dr. Lam's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in New York
Browse hematology & oncology specialists in New York ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NY
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NY
Which NY hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Exelixis Inc. Payments to Doctors
See all physicians who received payments from Exelixis Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology